Outcomes based on plasma biomarkers for the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (aHCC) Meeting Abstract
| Authors: | Rimassa, L.; Kelley, R. K.; Meyer, T.; Ryoo, B. Y.; Merle, P.; Park, J. W.; Blanc, J. F.; Lim, H. Y.; Tran, A.; Borgman-Hagey, A. E.; Clary, D. O.; Wang, E.; Cheng, A. L.; El-Khoueiry, A. B.; Abou-Alfa, G. K. |
| Abstract Title: | Outcomes based on plasma biomarkers for the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (aHCC) |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz247.006 |
| Language: | English |
| ACCESSION: | WOS:000491295502108 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz247.006 |
| Notes: | Meeting Abstract: 678PD -- Appears on pages v257-v258 of the abstract book -- Source: Wos |
